Funding to Support Additional Clinical Testing for Regulatory Approvals in the U.S. and E.U. Dublin, Ireland: 22nd June 2011… Crescent Diagnostics Ltd, (“Crescent”) a developer of novel tests for predicting osteoporotic fracture risk, today announced that it has raised Euro … more
News
Crescent Diagnostics Secures Euro 1.5 Million ($2.2 Million) for Its Predictive Test for Osteoporotic Fracture
Crescent Diagnostics Wins Prestigious Medical Technology Industry Award
Dublin, December 2, 2010 - Crescent Diagnostics was last night awarded gold in the ‘Innovation, Research, Development and Commercialisation’ category at the fourth annual Medical Technology Industry Excellence Awards, jointly hosted by Enterprise Ireland, IDA Ireland and the Irish Medical Devices … more

